The estimated Net Worth of Paul B Cleveland is at least $7 Mille dollars as of 15 January 2014. Paul Cleveland owns over 8,333 units of Sangamo Therapeutics Inc stock worth over $7,000 and over the last 16 years Paul sold SGMO stock worth over $0.
Paul has made over 8 trades of the Sangamo Therapeutics Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently Paul exercised 8,333 units of SGMO stock worth $41,915 on 15 January 2014.
The largest trade Paul's ever made was exercising 32,037 units of Sangamo Therapeutics Inc stock on 22 December 2010 worth over $85,859. On average, Paul trades about 3,046 units every 39 days since 2008. As of 15 January 2014 Paul still owns at least 8,333 units of Sangamo Therapeutics Inc stock.
You can see the complete history of Paul Cleveland stock trades at the bottom of the page.
Paul's mailing address filed with the SEC is C/O ALDER BIOPHARMACEUTICALS, INC., 11804 NORTH CREEK PARKWAY SOUTH, BOTHELL, WA, 98011.
Over the last 24 years, insiders at Sangamo Therapeutics Inc have traded over $87,969,621 worth of Sangamo Therapeutics Inc stock and bought 3,434,008 units worth $48,483,268 . The most active insiders traders include Capital Management, L.P.Ra ..., Le Roy C Kopp e Inc.Biogen Ma Inc. Biogen. On average, Sangamo Therapeutics Inc executives and independent directors trade stock every 21 days with the average trade being worth of $40,671. The most recent stock trade was executed by Inc.Biogen Ma Inc. Biogen on 26 September 2023, trading 6,000,000 units of SGMO stock currently worth $3,000,000.
for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.
Sangamo Therapeutics Inc executives and other stock owners filed with the SEC include: